American Conference Institute's 7th Annual Summit on
Monday, June 13 to Tuesday, June 14, 2016
New York Marriott Downtown, New York, NY
Attend the premier event where the industry leaders from both innovator and biosimilar companies convene to formulate solutions to the complex regulatory and patent challenges ahead as the first biosimilars are a reality in the U.S
Since the passage of the historic Biologics Price Competition & Innovation Act (BPCIA) in 2010, the key figures shaping the evolving biosimilar landscape---in-house counsel from leading biopharmaceutical companies, top IP and regulatory lawyers, key policy and industry insiders, the FDA, and the FTC- have convened to formulate solutions to the challenges facing the industry at the ACI Biosimilars conference.
Just last year, over 140 industry leaders converged in NY at this event to discuss the first U.S. biosimilar applications. While the first biosimilar came on market in September, there are still many questions outstanding and the patent dance has already begun for these products in both Federal Court and the PTAB. With the second wave of applications on the horizon and more guidance on the way, it is more important than ever to get the most updated cutting edge information from the leading authorities in this rapidly developing and critical space. Topics to be discussed this year include:
Hear What Prior Attendees Are Saying about this Annual Leading Event:
Full conference details are on the way shortly. If you are interested in speaking at this event, contact Bolam Kim at email@example.com. For information on sponsoring or exhibiting at this event, contact Esther Fleischhacker at firstname.lastname@example.org.
Based on past success, spaces will fill up quickly. Register now by calling 1-888-224-2480, faxing your registration form to 1-877-927-1563, or registering online.
- Actions -
- Share -
Mon, Jun 13, 2016
Tue, Jun 14, 2016
New York Marriott Downtown
New York, NY